HF
NUVB icon

HRT Financial’s Nuvation Bio NUVB Stock Holding History

HRT Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
+2,207,779
New +$10.8M 0.02% 676
2025
Q4 		– Sell
-631,154
Closed -$2.33M – 3765
2025
Q3 		$2.33M Buy
+631,154
New +$1.72M 0.01% 1058
2024
Q1 		– Sell
-154,066
Closed -$232K – 2844
2023
Q4 		$232K Buy
154,066
+142,247
+1,204% +$183K ﹤0.01% 1732
2023
Q3 		$15K Buy
+11,819
New +$19.7K ﹤0.01% 2092
2023
Q2 		– Sell
-108,463
Closed -$180K – 3004
2023
Q1 		$180K Sell
108,463
-223,492
-67% -$453K ﹤0.01% 1947
2022
Q4 		$637K Buy
+331,955
New +$672K 0.01% 1256
2022
Q3 		– Sell
-41,497
Closed -$134K – 3282
2022
Q2 		$134K Buy
+41,497
New +$181K ﹤0.01% 2364
2021
Q1 		– Sell
-10,879
Closed -$127K – 3014
2020
Q4 		$127K Buy
+10,879
New +$113K ﹤0.01% 1596

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

HRT Financial's NUVB Position: Q2 2026 in Review

HRT Financial opened a new position in Nuvation Bio (NUVB) in Q2 2026: 2,207,779 shares worth $12.5M. The stake represents 0.02% of the portfolio and ranks #676 among its holdings. This is a return to the name: HRT Financial previously reported a position in NUVB as recently as Q3 2025.

HRT Financial first reported a position in NUVB in Q4 2020 and has held it in 8 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • HRT Financial held 2,207,779 shares of Nuvation Bio worth $12.5M as of Q2 2026.
  • Nuvation Bio was a new HRT Financial position in Q2 2026.
  • Nuvation Bio made up 0.02% of HRT Financial's portfolio in Q2 2026, its #676 holding.
  • HRT Financial first reported a position in Nuvation Bio in Q4 2020 and has held it in 8 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.